The Full Wiki

More info on SEP-227162

SEP-227162: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

(Redirected to SEP-227,162 article)

From Wikipedia, the free encyclopedia

SEP-227,162
Systematic (IUPAC) name
 ?
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Chemical data
Formula  ?
Mol. mass  ?
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

SEP-227,162 is an antidepressant being developed by Sepracor which is currently in clinical trials. It acts as a serotonin-norepinephrine reuptake inhibitor.

References

External links


SEP-227162 is an antidepressant drug being developed by Sepracor which is currently in clinical trials. It is a so-called triple reuptake inhibitor (TRI), or serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It is closely related to SEP-225289 which is also being developed by Sepracor.

References








Got something to say? Make a comment.
Your name
Your email address
Message